Methods for treating ocular angiogenesis, retinal edema, retinal ischemia, and diabetic retinopathy using selective rtk inhibitors

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP12194855.8

公开号：

EP2594264A1

申请日:

2006.02.23

申请国别(地区):

EP

年份:

2013

代理人:

摘要：

The present invention provides compositions and methods for treating ocular neovascularization, angiogenesis, retinal edema, diabetic retinopathy, and/or retinal ischemia in order to prevent the loss of visual acuity associated with such conditions. More specifically, the present invention provides compositions containing receptor tyrosine kinase (RTK) inhibitors having unique binding profiles and their use in treating ocular disorders.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/